| Excerpt | Relevance | Reference |
|---|
| "The authors hypothesized that carvedilol controlled-release plus lisinopril combination therapy (C+L) would increase endothelial function and decrease oxidative stress to a greater extent than hydrochlorothiazide plus lisinopril combination therapy (H+L) in obese patients with hypertension." | 9.16 | Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension. ( Bank, AJ; Gonzalez-Campoy, JM; Katz, H; Kelly, AS; Metzig, AM; Rudser, KD; Thalin, M, 2012) |
| "The authors hypothesized that carvedilol controlled-release plus lisinopril combination therapy (C+L) would increase endothelial function and decrease oxidative stress to a greater extent than hydrochlorothiazide plus lisinopril combination therapy (H+L) in obese patients with hypertension." | 5.16 | Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension. ( Bank, AJ; Gonzalez-Campoy, JM; Katz, H; Kelly, AS; Metzig, AM; Rudser, KD; Thalin, M, 2012) |